Innovative inhaler: the Novolizer
On the global market
The Novolizer is now on sale on the global market and the number of asthma and COPD drugs for which it can be used will soon be increased. Various pharmaceutical companies are involved in its further development. In addition, De Boer and Frijlink and their team of specialists are currently working on a special disposable inhaler (the Twincer) for administering drugs for conditions such as cystic fibrosis and tuberculosis. The pharmaceutical industry is already keenly anticipating this new inhaler, as it is also suitable for administering flu jabs and vaccinations against various other infectious diseases. It is thought that the Twincer will be available for use by patients in just a few years.
On 21 April 2010, Anne de Boer and Erik Frijlink were awarded the Wubbo Ockels prize for the successful development of this innovative Novolizer inhaler.
Last modified: | 22 May 2018 10.35 a.m. |
More news
-
20 January 2023
Carmem M. Gilardoni wins the Ehrenfest-Afanassjewa thesis prize 2022
Carmem M. Gilardoni wins the Ehrenfest-Afanassjewa thesis prize 2022
-
17 January 2023
The quest for the perfect paint
Hanneke Siebe is working on a fullly sustainable paint, based on gum arabic.
-
16 January 2023
In search of the coveted safer, better, longer-lasting battery: BatteryNL kicks off
On the 12th of January a large number of parties involved in the development of batteries in the Netherlands – small companies, multinationals and knowledge institutes – attended the kick off of the BatteryNL consortium. Their goal is to develop the...